Vestibular (V)

LL104 - Benign Paroxysmal Positional Vertigo: Science & Protocols for Successful Treatment & Happy Patients

Wednesday, March 30, 2022

8:30 AM – 12:00 PM CT

Location: 227

Earn 0.3 CEUs

Lead Presenter(s)

Richard E. Gans, PhD

Founder & CEO
American Institute of Balance
Largo, Florida

Disclosure: Financial Disclosures: American Institute of Balance- Ownership Interest includes stock, stock options, patent or other intellectual property
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.

Presenter(s)

Joseph Sakumura, AuD

Director - Centers of Specialty Care
The American Institute of Balance
Largo, Florida

Disclosure: Financial Disclosures: I do not have any relevant financial relationships with anything to disclose.
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.
Brittany Fauble, AuD

Director of Diagnostic & Clinical Services
The American Institute of Balance
Largo , Florida

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
AS

Alyssa Steinweis

Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Audiologists have an opportunity to be a primary provider in the non-medical treatment of the #1 cause of vertigo, Benign Paroxysmal Positional Vertigo (BPPV). This Learning Lab will bring together historical and evidence based literature and practices to ensure the best outcomes with Canalith Repositioning Maneuvers (CRM). The AIB faculty will bring its experience in treating over 14,000 patients during a hands-on training session allowing attendees to practice and be coached on CRM protocols for all canal variants of BPPV.

Learning Objectives:

Explain the pathophysiology and biochemistry of BPPV.
Describe the most effective Canalith Reposting Maneuvers (CRM) and protocols for all forms of BPPV.
Perform Canalith Repositioning Maneuvers (CRM) for all semicircular canals and variants of BPPV.